362results about How to "Relieve clinical symptoms" patented technology

The invention relates to a Chinese medicinal composition for treating insomnia and a preparation method of a preparation thereof. The Chinese medicinal composition comprises the following raw material components in parts by weight: 10-20 parts of baikal skullcap root, 10-20 parts of fructus gardenia, 25-35 parts of tuber fleeceflower stem, 15-25 parts of fried date kernel, 15-25 parts of silktreealbizzia bark, 10-20 parts of thinleaf milkwort root-bark, 25-35 parts of dragon bone, 25-35 parts of oyster, 5-15 parts of coptis root, 10-20 parts of indian buead, 5-15 parts of liquoric root, 15-25 parts of white paeony root, 25-35 parts of mother of pearl and 5-15 parts of green tangerine peel. The method comprises the following steps of: smashing the dragon bone and oyster, and grinding the mother of pearl; mixing the remaining medicaments, smashing, adding 75 percent ethanol for performing reflux extraction for 2-3 times, combining filtrates, adding dragon bone powder and oyster powder into the filtrate, and concentrating to a thick extract; and drying to obtain powder. The Chinese medicinal composition has the characteristics of small dosage and small side effect, can be used for relieving clinical symptoms, and has a remarkable treatment effect; and the aims of treating internally and externally and treating both principal and secondary aspects of a disease can be fulfilled.

The invention provides a Chinese medicament for treating children's constipation which comprises the following main constituents (by weight portions): white atractylodes rhizome 6-18, bitter orange 3-10 parts, apricot kernel 6-10, magnolia bark 3-10, radish seeds 6-15, cassia seed 6-12 and aloe 1-6. The medicament can be prepared into particles, oral liquids, capsules, tablets and bag infusions.

The invention discloses Chinese medicinal magneto-therapy externally applied plaster applied to acupuncture points and used for treating asthma. The externally applied plaster comprises the following components in part by weight: 10 to 30 parts of white mustard seed, 10 to 30 parts of corydalis tuber, 10 to 20 parts of euphorbia kansui, 10 to 20 parts of roasted asarum, 5 to 15 parts of roasted ephedra, 5 to 15 parts of unprocessed pinellia tuber, 5 to 10 parts of roasted liquorice, 10 to 20 parts of roasted sessile stemona root, 5 to 10 parts of cinnamon, 5 to 10 parts of semen lepidii, 60 to 80 parts of ginger juice, 10 to 15 parts of roasted gleditsia sinensis, 1 to 1.5 parts of musk, 10 to 15 parts of arisaema cum bile, 10 to 20 parts of fritillaria, 10 to 20 parts of earthworm, 1 to 5 parts of borneol, 10 to 20 parts of bitter almond, 10 to 20 parts of swallowwort rhizome, and 10 to 20 parts of roasted common coltsfoot flower. The externally applied plaster is characterized by consisting of a flaky sticking matrix, a magnetic block and Chinese medicinal ointment sequentially from inside to outside. The externally applied plaster has the characteristics of scientific compatibility of Chinese medicaments, reasonable content of each component, simplicity in preparation method, safety and convenience in use, definite and obvious curative effect and the like. By matching acupuncture point application, the effective rate of the externally applied plaster for treating the asthma reaches 90 percent.

The invention discloses a traditional Chinese medicine composition for treating type II diabetes. The traditional Chinese medicine composition mainly consists of astragalus, codonopsis pilosula, rehmannia root, Chinese yam, fragrant solomonseal rhizome, wolfberry fruit, radix asparagi, figwort root, glossy privet fruit, kudzuvine root, balsam pear, the root of three-nerved spicebush, mulberry and cortex lycii radicis. The traditional Chinese medicine composition can relieve the thirsty symptom caused by the type II diabetes, regulate blood sugar and treat various complications caused by diabetes and is obvious in effect of the type II diabetes.

The invention discloses a compound combined medicine for treating ulcerative colitis. The compound combined medicine is prepared from the following components in parts by weight: 2-9 parts of coptis chinensis, 6-15 parts of scutellaria baicalensis, 10-30 parts of patrinia, 6-20 parts of fried angelica sinensis, 5-20 parts of parched white peony roots, 5-15 parts of raw garden burnets, 5-20 parts of lithospermum, 5-15 parts of madders, 6-15 parts of radix angelicae, 3-12 parts of simmered elecampane and 2-6 parts of raw liquorice. The invention further discloses a preparation method and application of the ompound combined medicine. The invention provides an effective therapeutic medicine for treating the refractory diseases ulcerative colitis and is economical and practical and broad in clinical application prospect. The compound combined medicine is simple in preparation method, simple, fast, efficient and easy to operate, and prepared granules are convenient to carry and take.

The invention relates to composition with effects of increasing bone mineral density, preventing inflammation and easing pain and a preparation method thereof. The composition with the effects of increasing bone mineral density, preventing inflammation and easing pain is prepared from the following bulk pharmaceutical chemicals ingredients of chondroitin sulfate, glucosamine hydrochloride, calcium carbonate, sodium hyaluronate, dimethyl sulfone and radix puerariae extract. The invention further relates to a film-coated tablet prepared from the composition and a preparation method of the film-coated tablet. The composition has a better curing effect of increasing bone mineral density, and all ingredients have a synergistic effect, can easily improve calcium absorption and can well increase bone mineral density; animal function experiments prove that the composition can obviously improve the thighbone weight, the bone calcium content, the thighbone middle point density and the thighbone telecentric end bone mineral density of a rat.

The invention provides new application of a pharmaceutical composition. The pharmaceutical composition is composed of the following components in percentage by weight: 15-35% of glucosamine hydrochloride, 20-40% of biological calcium carbonate, 5-20% of rhizoma drynariae extracts, 1-5% of casein phosphopeptides, 10-20% of chondroitin sulfate, and 10-30% of epimedium extracts. The new application is that the pharmaceutical composition is used for preparing drugs or health-care products for preventing or treating osteoporosis.

The invention discloses a traditional Chinese medicine composition for treating type II diabetes. , composed of Digupi, can relieve the thirst symptoms caused by type II diabetes, and at the same time can regulate blood sugar, and can treat various complications caused by diabetes, and has a significant effect on type II diabetes.

The invention, belonging to the field of traditional Chinese medicine pharmacy, relates to a medicinal preparation for treating plasma cell mastitis and a preparation method thereof. The medicinal preparation for treating plasma cell mastitis takes liver smoothing, heat clearing, vigoration of blood circulation and bind dissipating as therapeutic principles, and comprises the following traditional Chinese pharmaceutical ingredients: radix bupleuri, scutellaria baicalensis, cape jasmine fruit, cortex moutan, red paeony root, dandelion, health hawthorn, hedyotidis herba and other auxiliary materials. Clinical outcomes show that the medicinal preparation can clear away hepatic fire and stomach toxic heat to achieve the effects of smoothening liver-Qi, strengthening spleen-Qi and dispersing carbuncle and swelling, and can effectively reduce inflammatory response and alleviate clinical symptoms, prevent the further progress of the disease, and mitigate the mental pressure of the patient. The medicinal preparation has the advantages of convenient taking, less dosage and no side effects of long term dosages, and has good comments made by patients.

The invention discloses a compound enrofloxacin injection for animals and a preparation method thereof, which aims to provide the enrofloxacin injection for the animals and the preparation method thereof, wherein, the enrofloxacin injection for the animals can treat swine enzootic pneumonia, is quick to take effect, decreases drug resistance, and can treat symptoms and root causes; and the preparation method has a simple process and is easy to realize. The injection comprises the following compositions by weight portion: 0.5 to 5kg of enrofloxacin, 1 to 10kg of lincomycin hydrochloride, 0.01 to 0.05kg of sodium hydroxide, 0.1 to 2kg of doxofylline, 0.2kg of sodium sulfite, 0.01kg of EDTA-2Na, 30kg of propanediol, and the balance being water for injection. The injection adopts a compound preparation of an antimicrobial drug and antibiotics; due to the combined use of the enrofloxacin and the lincomycin hydrochloride as well as the doxofylline, the injection is quick to take effect to the swine enzootic pneumonia, is effective and highly efficient, reduces the probability of the drug resistance, can apparently relieve clinical symptoms caused by the swine enzootic pneumonia, can treat symptoms and root causes, and increase the weight of pigs.

The invention provides the application of carubinose in preparing medicine that can treat lung acute inflammation diseases. The molecular formula of carubinose is C6H12O6, the structure is D-carubinose. Said medicine comprises medicine acceptable shaping agent or carrying agent. The produced dosage form mainly comprises liquid dosage form, granule, tablet, gas spraying form, drop or pill. The invention can reduce the lung tissue TNF-alpha level of mice ALT model induced by LPS, release neutral granulocyte wettability in lung tissue, inhibit capillary blood permeability, decrease protein exudation and lung water content, reduce MPO level in BALF supernatant and improve pathologic change for lung tissue inflammation. The invention discloses the functions of anti-inflammation, anti-oxidation and pneumochysis reduction of carubinose.

The invention discloses full-nutrient formula powder special for nephrosis and a preparing method thereof. The full-nutrient formula powder comprises, by weight, 40-55 parts of carbohydrate, 10-40 parts of vegetable fat powder, 5-15 parts of medium chain triglyceride powder, 4-16 parts of high-quality protein, 1-5 parts of a sweetening agent, 0-17 parts of water-soluble dietary fiber, 0-1.5 partsof an emulsifier, 0-2 parts of a thickener, 0-2 parts of low sodium salt, 0-2 parts of an acidity regulator, 0-1.5 parts of vitamin premix powder, 0-2.5 parts of mineral premix powder, 0-1 part of essence and 0-1.5 parts of polyunsaturated fat. The preparing method includes the steps of a, weighing; b, pulverizing; c, premixing; d, total mixing; e, subpackaging. The full-nutrient formula powder can serve as the single nutrient source to meet the requirements of nephrosis patients for nutrients and can supplement the nutrients necessary to the nephrosis patients.